Validation du questionnaire QLQ-C30 de EORTC dans sa version tunisienne
DOI :
https://doi.org/10.62438/tunismed.v103i4.5260Mots-clés :
Carcinome bronchique non à petites cellules, Qualité de vie , Validation , EORTC QLQ-C30Résumé
Objectif : Tester la validité et la fiabilité du QLQ-C30 de l’EORTC dans sa version dialectale tunisienne pour les patients atteints de cancer du poumon.
Méthodes : Un total de 300 patients sous chimiothérapie pour un cancer du poumon ont été inclus dans cette étude transversale. Les participants ont répondu à l'auto-questionnaire QLQ-C30 dans la version tunisienne, puis dans la version arabe, 15 jours plus tard. Les analyses statistiques ont été réalisées par SPSS 22.
Résultats : La version tunisienne s’est avérée fiable et valide pour les patients tunisiens atteints de cancer. Sept parmi les huit dimensions du QLQ-C30 présentaient une fiabilité élevée (α de Cronbach >0,7). Dans notre analyse, les dimensions du QLQ-C30 les plus déterminantes pour la santé globale étaient le fonctionnement physique, le fonctionnement cognitif, la fatigue et la dyspnée. La corrélation avec la version arabe était presque parfaite ; les scores moyens des différentes dimensions étaient statistiquement corrélés. Les corrélations interclasses ont confirmé la validité convergente externe. La validité discriminante a été confirmée puisque la valeur de corrélation du score des échelles des symptomes entre elles était plus élevée que celle avec toute échelle fonctionnelle, et inversement..
Conclusions : La version tunisienne du QLQ-C30, récemment rédigée, est un outil fiable et valide pour évaluer la qualité de vie des patients tunisiens atteints de cancer du poumon.
Téléchargements
Références
Park KU. Assessment of change of quality of life in terminally ill patients under cancer
pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a
Korean sample. Oncology. 2008;74 Suppl 1:7–12.
Ameri H, Yousefi M, Yaseri M, Nahvijou A, Arab M, Akbari Sari A. Mapping EORTC-QLQC30 and QLQ-CR29 onto EQ-5D-5L in Colorectal Cancer Patients. J Gastrointest Cancer.
Apr 12;
Demirci S, Eser E, Ozsaran Z, Tankisi D, Aras AB, Ozaydemir G, et al. Validation of the
Turkish versions of EORTC QLQ-C30 and BR23 modules in breast cancer patients. Asian
Pac J Cancer Prev APJCP. 2011;12(5):1283–7.
El ayoubi H. Comparison of Reliability and Validity of the Breast Cancer depression
anxiety stress scales (DASS-21) with the Beck Depression Inventory-(BDI-II) and
Hospital Anxiety and Depression Scale (HADS). Int J Behav Res Psychol. 2016;4(4):197–
Gadisa DA, Gebremariam ET, Ali GY. Reliability and validity of Amharic version of EORTC
QLQ-C30 and QLQ-BR23 modules for assessing health-related quality of life among
breast cancer patients in Ethiopia. Health Qual Life Outcomes. 2019 Dec;17(1):182.
Musarezaie A, Khaledi F, Esfahani HN, Ghaleghasemi TM. Factors affecting quality of life and fatigue in patients with leukemia under chemotherapy. J Educ Health Promot.
;3:64.
Pompili C, Koller M, Velikova G, Franks K, Absolom K, Callister M, et al. EORTC QLQ-C30
summary score reliably detects changes in QoL three months after anatomic lung
resection for Non-Small Cell Lung Cancer (NSCLC). Lung Cancer Amst Neth.
;123:149–54.
Oñate-Ocaña LF, Alcántara-Pilar A, Vilar-Compte D, García-Hubard G, Rojas-Castillo E,
Alvarado-Aguilar S, et al. Validation of the Mexican Spanish version of the EORTC C30
and STO22 questionnaires for the evaluation of health-related quality of life in patients
with gastric cancer. Ann Surg Oncol. 2009 Jan;16(1):88–95.
Tan ML, Idris DB, Teo LW, Loh SY, Seow GC, Chia YY, et al. Validation of EORTC QLQC30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer
patients in Singapore. Asia-Pac J Oncol Nurs. 2014 Apr;1(1):22–32.
Tomaszewski KA, Püsküllüoğlu M, Biesiada K, Bochenek J, Nieckula J, Krzemieniecki K.
Validation of the Polish Version of the EORTC QLQ-C30 and the QLQ-OG25 for the
Assessment of Health-Related Quality of Life in Patients with Esophagi-Gastric Cancer. J
Psychosoc Oncol. 2013 Mar;31(2):191–203.
Eberhardt WEE, Mitchell A, Crowley J, Kondo H, Kim YT, Turrisi A, et al. The IASLC Lung
Cancer Staging Project: Proposals for the Revision of the M Descriptors in the
Forthcoming Eighth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol Off
Publ Int Assoc Study Lung Cancer. 2015 Nov;10(11):1515–22.
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The
IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings
in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac
Oncol Off Publ Int Assoc Study Lung Cancer. 2016 Jan;11(1):39–51.
Huijer HAS, Sagherian K, Tamim H. Validation of the Arabic version of the EORTC quality
of life questionnaire among cancer patients in Lebanon. Qual Life Res. 2013
Aug;22(6):1473–81.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European
Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument
for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 Mar
;85(5):365–76.
Fayer P, Aaronson NK, Bjordal K, Sullian M. EORTC QLQ-C30 Scoring Manual. [Internet].
EORTC Quality of Life Group, Bressels; 1995. Available from:
https://www.eortc.org/app/uploads/sites/2/2018/02/SCmanual.pdf
Nunnally JC, Bernstein IH. Psychometric theory. 3rd ed. New York: McGraw-Hill; 1994.
p. (McGraw-Hill series in psychology).
DeVellis RF. Scale development: theory and applications. Fourth edition. Los Angeles:
SAGE; 2017. 262 p.
Hays RD, Hayashi T. Beyond internal consistency reliability: Rationale and user‟s guide
for Multitrait Analysis Program on the microcomputer. Behav Res Methods Instrum
Comput. 1990 Mar 1;22(2):167–75.
Fayers PM, Machin D. Quality of life: The assessment, analysis, and reporting of patient reported outcomes. Third edition. Chichester, West Sussex, UK ; Hoboken, NJ: John Wiley & Sons Inc; 2016.
Everitt B. The Cambridge dictionary of statistics. 2nd ed. Cambridge, UK ; New York:
Cambridge University Press; 2002. 410 p.
Yun YH, Park YS, Lee ES, Bang SM, Heo DS, Park SY, et al. Validation of the Korean
version of the EORTC QLQ-C30. Qual Life Res Int J Qual Life Asp Treat Care Rehabil.
May;13(4):863–8.
Shih CL, Chen CH, Sheu CF, Lang HC, Hsieh CL. Validating and Improving the Reliability
of the EORTC QLQ-C30 Using a Multidimensional Rasch Model. Value Health. 2013
Jul;16(5):848–54.
Jaiyesimi AO, Sofela EA, Rufai AA. Health related quality of life and its determinants in
Nigerian breast cancer patients. Afr J Med Med Sci. 2007 Sep;36(3):259–65.
Kootstra J, Hoekstra-Weebers JEHM, Rietman H, de Vries J, Baas P, Geertzen JHB, et al.
Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage
I/II breast cancer patients: a prospective longitudinal study. Ann Surg Oncol. 2008
Sep;15(9):2533–41.
Cocks K, Wells JR, Johnson C, Schmidt H, Koller M, Oerlemans S, et al. Content validity
of the EORTC quality of life questionnaire QLQ-C30 for use in cancer. Eur J Cancer Oxf
Engl 1990. 2023 Jan;178:128–38.
Daroszewski C, Stasiewicz M, Jaźwińska-Tarnawska E, Rachwalik A, Mura E, LubochKowal J, et al. Quality of Life in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Palliative Chemotherapy. Adv Exp Med Biol. 2019;1160:11–8.
Chie WC, Yang CH, Hsu C, Yang PC. Quality of life of lung cancer patients: validation of
the Taiwan Chinese version of the EORTC QLQ-C30 and QLQ-LC13. Qual Life Res Int J
Qual Life Asp Treat Care Rehabil. 2004 Feb;13(1):257–62.
Dean GE, Abu Sabbah E, Yingrengreung S, Ziegler P, Chen H, Steinbrenner LM, et al.
Sleeping with the enemy: sleep and quality of life in patients with lung cancer. Cancer
Nurs. 2015 Feb;38(1):60–70.
Brown ML, Lipscomb J, Snyder C. The burden of illness of cancer: economic cost and
quality of life. Annu Rev Public Health. 2001;22:91–113.
Kajimoto Y, Honda K, Suzuki S, Mori M, Tsubouchi H, Nakao K, et al. Association
between financial toxicity and health-related quality of life of patients with gynecologic
cancer. Int J Clin Oncol. 2023 Mar;28(3):454–67.
Shim S, Kang D, Kim N, Han G, Lim J, Kim H, et al. Validation of Korean Version of the
COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
Cancer Res Treat. 2022 Jul;54(3):834–41.
Dar MA, Chauhan R, Trivedi V, Kumar R, Dhingra S. Assessing the Prevalence of
Financial Toxicity, its Predictors and Association with Health- Related Quality of Life
Among Radiation Oncology Patients in India: A Cross-Sectional Patient Reported
Outcome Study. Int J Radiat Oncol Biol Phys. 2023 May 1;116(1):157–65.
Belloumi N, Maalej Bellaj S, Bachouche I, Chermiti Ben Abdallah F, Fenniche S.
Comparison of Sleep Quality before and after Chemotherapy in Locally Advanced
Nonsmall Cell Lung Cancer Patients: A Prospective Study. Sleep Disord. 2020 Jul
;2020:1–8.
Asiimwe JB, Nagendrappa PB, Atukunda EC, Kamatenesi MM, Nambozi G, Tolo CU, et al.
Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic
Review and Meta-Analysis. Evid-Based Complement Altern Med ECAM.
;2021:9963038.
Molassiotis A, Fernández-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of
complementary and alternative medicine in cancer patients: a European survey. Ann
Oncol Off J Eur Soc Med Oncol. 2005 Apr;16(4):655–63.
Wode K, Henriksson R, Sharp L, Stoltenberg A, Hök Nordberg J. Cancer patients‟ use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC
Complement Altern Med. 2019 Mar 13;19(1):62.
Fichiers supplémentaires
Publiée
Numéro
Rubrique
Catégories
Licence
Merci de créditer les auteurs lors de toute citation : La Tunisie Médicale (2025)
Ce travail est disponible sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
